Fledgling biotechs and medical-technology startups in the U.S. and Europe have found a new source of funding for their costly research: China.
SUBSCRIBE
Biohealth Innovation
Founding Member of
Biohealth Innovation
Fledgling biotechs and medical-technology startups in the U.S. and Europe have found a new source of funding for their costly research: China.